Compounded Medication – Prescription Only

This product is a compounded sublingual formulation containing tadalafil and is dispensed only pursuant to a valid prescription issued by a licensed healthcare provider. In compounding practice, tadalafil may be prepared in alternative dosage forms when a provider determines that individualized formulation, concentration, or delivery considerations are clinically appropriate for a specific patient. This product is not available for self-selection and may only be dispensed following provider authorization.

Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). The FDA does not evaluate compounded formulations for safety, effectiveness, or manufacturing quality. This regulatory status is distinct from FDA-approved tadalafil products, including brand-name Cialis® and FDA-approved generic tadalafil tablets. Compounding is performed by a state-licensed pharmacy pursuant to a patient-specific prescription.

This page provides general, non-promotional information for educational and compliance purposes only. It does not describe intended use, therapeutic benefit, sexual performance outcomes, or expected clinical results. No claims are made regarding efficacy, response, or suitability for any particular individual.

General Scientific Information (Non-Therapeutic)

Tadalafil has been studied in clinical and scientific research for its pharmacologic classification as a phosphodiesterase type 5 (PDE-5) inhibitor and its effects on cyclic guanosine monophosphate (cGMP) signaling pathways under controlled conditions. Descriptions of pharmacologic class or biochemical mechanisms are provided solely for general scientific context. No claims are made regarding safety, effectiveness, or outcomes.

Formulation Considerations

Compounded tadalafil may be prepared in alternative dosage forms, such as oral troches, when a licensed healthcare provider determines that individualized formulation considerations are appropriate. Differences in dosage form, excipients, or strength reflect formulation parameters and do not imply differences in clinical effect or equivalence to FDA-approved products.

Contraindications

Compounded tadalafil should not be used in individuals who have a known hypersensitivity or allergy to tadalafil or any component of the compounded formulation; are taking nitrates or nitric oxide donors; have severe cardiovascular conditions for which vasodilatory effects are contraindicated; or have other conditions in which tadalafil use is contraindicated as determined by the prescribing healthcare provider.

Warnings and Precautions

Tadalafil may cause systemic vasodilatory effects. Caution is advised in individuals with cardiovascular disease, blood pressure abnormalities, hepatic or renal impairment, or those taking medications that may interact with PDE-5 inhibitors. Patients should inform their healthcare provider of all medical conditions, medications, and supplements prior to use. Compounded tadalafil should be used only as prescribed and supervised by a licensed healthcare provider.

Potential Side Effects

Reported side effects associated with tadalafil may include headache, flushing, nasal congestion, dizziness, gastrointestinal discomfort, back pain, muscle aches, or changes in blood pressure. Serious adverse reactions are uncommon but may occur. Patients should seek immediate medical attention if they experience severe adverse effects, symptoms suggestive of cardiovascular events, vision changes, hearing changes, or signs of a severe allergic reaction.